Using cryogenic catheters for lung biopsy and treatment
Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.
This study is testing a new way to take lung biopsies and treat lung lesions using cold technology to see if it can be safer and more effective than traditional methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT05948904 on ClinicalTrials.gov |
What this trial studies
This study aims to develop a standardized technique for using cryogenic catheters in transbronchial cryobiopsy and cryoablation of pulmonary lesions. By utilizing an ex-vivo human lung model, the researchers will explore the effectiveness of cryotechnology as a minimally invasive alternative to traditional surgical lung biopsy and resection. The goal is to improve the quality of tissue samples and reduce complications associated with current methods. This approach could enhance patient safety and outcomes in lung disease management.
Who should consider this trial
Good fit: Ideal candidates for this study are patients undergoing lung transplant surgery.
Not a fit: Patients who are organ donors ineligible to donate lungs or healthy individuals may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this technique could provide a safer and more effective method for diagnosing and treating lung lesions.
How similar studies have performed: While promising results have been achieved using cryotechnology, this specific approach to transbronchial interventions is novel and has not been extensively tested in humans.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing lung transplant surgery Exclusion Criteria: * Organ donor ineligible to donate lungs * Healthy individuals
Where this trial is running
Montreal, Quebec
- Chum — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Study coordinator: Moishe Liberman, MD
- Email: moishe.liberman@umontreal.ca
- Phone: 514-890-8000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.